State Of Wyoming Nurix Therapeutics, Inc. Transaction History

State Of Wyoming

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$7.88 - $14.82 $8,620 - $16,213	-1,094 Reduced 83.96%	209 $3,000
Q1 2022 May 13, 2022	BUY	$12.94 - $29.65 $5,460 - $12,512	422 Added 47.9%	1,303 $18,000
Q4 2021 Feb 11, 2022	BUY	$26.43 - $34.5 $3,145 - $4,105	119 Added 15.62%	881 $26,000
Q3 2021 Feb 11, 2022	SELL	$22.71 - $36.69 $10,423 - $16,840	-459 Reduced 37.59%	762 $23,000
Q2 2021 Feb 11, 2022	BUY	$24.21 - $35.89 $19,513 - $28,927	806 Added 194.22%	1,221 $32,000
Q1 2021 Feb 08, 2022	BUY	$26.98 - $50.17 $11,196 - $20,820	415 New	415 $13,000

181

68.1M

78K

53.8K

Ticker NRIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,147,800
Market Cap $1.03B
Description
Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.